These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 20203507)
41. Postinfectious irritable bowel syndrome. Barbara G; Cremon C; Pallotti F; De Giorgio R; Stanghellini V; Corinaldesi R J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S95-7. PubMed ID: 19300138 [TBL] [Abstract][Full Text] [Related]
42. Treating irritable bowel syndrome with probiotics: the evidence. Parkes GC; Sanderson JD; Whelan K Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566 [TBL] [Abstract][Full Text] [Related]
43. Protease activated receptor 2: a new target for IBS treatment. Bueno L Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():95-102. PubMed ID: 18924448 [TBL] [Abstract][Full Text] [Related]
44. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775 [TBL] [Abstract][Full Text] [Related]
45. The spectrum of irritable bowel syndrome: A clinical review. Gilkin RJ Clin Ther; 2005 Nov; 27(11):1696-709. PubMed ID: 16368443 [TBL] [Abstract][Full Text] [Related]
46. Diagnostic and therapeutic strategies in the irritable bowel syndrome. Cremonini F; Talley NJ Minerva Med; 2004 Oct; 95(5):427-41. PubMed ID: 15467518 [TBL] [Abstract][Full Text] [Related]
47. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Grover M; Herfarth H; Drossman DA Clin Gastroenterol Hepatol; 2009 Jan; 7(1):48-53. PubMed ID: 18848909 [TBL] [Abstract][Full Text] [Related]
48. Infection, inflammation, and the irritable bowel syndrome. Spiller R; Garsed K Dig Liver Dis; 2009 Dec; 41(12):844-9. PubMed ID: 19716778 [TBL] [Abstract][Full Text] [Related]
49. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons. Balestra B; Vicini R; Cremon C; Zecchi L; Dothel G; Vasina V; De Giorgio R; Paccapelo A; Pastoris O; Stanghellini V; Corinaldesi R; De Ponti F; Tonini M; Barbara G Neurogastroenterol Motil; 2012 Dec; 24(12):1118-e570. PubMed ID: 22937879 [TBL] [Abstract][Full Text] [Related]
50. Review article: probiotics and prebiotics in irritable bowel syndrome. Spiller R Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993 [TBL] [Abstract][Full Text] [Related]
51. Functional gastrointestinal disorders and mast cells: implications for therapy. Barbara G; Stanghellini V; De Giorgio R; Corinaldesi R Neurogastroenterol Motil; 2006 Jan; 18(1):6-17. PubMed ID: 16371078 [TBL] [Abstract][Full Text] [Related]